Patent: 6,022,539
✉ Email this page to a colleague
Summary for Patent: 6,022,539
| Title: | Amelioration of peyronie\'s disease |
| Abstract: | A method of treating an individual suffering from Peyronie\'s disease. Collagenase is injected into a fibrous Peyronie\'s plaque in the penis of the individual suffering from the disease. The penis immediately after injection, is immobilized and maintained immobile for several hours. The collagenase is in a pharmaceutically acceptable carrier in a concentration of about 20,000 to about 40,000 ABC units per ml., and the amount and concentration of the collagenase is effective to soften and/or rupture the plaque whereby the erectile deviation caused by the plaque is ameliorated |
| Inventor(s): | Wegman; Thomas L. (North Merrick, NY) |
| Assignee: | Advance Biofactures of Curacao (Curacao, AN) |
| Application Number: | 09/325,224 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,022,539 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,022,539
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Smith & Nephew, Inc. | SANTYL | collagenase | Ointment | 101995 | 06/04/1965 | ⤷ Try a Trial | 2039-03-29 |
| Auxilium Pharmaceuticals, Inc. | XIAFLEX | collagenase clostridium histolyticum | For Injection | 125338 | 02/02/2010 | ⤷ Try a Trial | 2039-03-29 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 6,022,539
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Sweden | 0001914 | ⤷ Try a Trial |
| Norway | 333945 | ⤷ Try a Trial |
| Norway | 20002686 | ⤷ Try a Trial |
| Ireland | 20000402 | ⤷ Try a Trial |
| United Kingdom | 2352173 | ⤷ Try a Trial |
| United Kingdom | 0011969 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
